Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Abstract

The primary objective of the study is to investigate neuroregenerative efficacy (proof of concept) of intrathecal treatment with autologous MSCs as measured by neurophysiological parameters in patients with progressive MS. Secondary objectives are to assess neuroregenerative efficacy as measured by other neurophysiological parameters as well as clinical, opthalmological and MRI modalities, and to assess safety of the treatment procedure. Phase: PHASE1, PHASE2 Status: ACTIVE_NOT_RECRUITING Conditions: Multiple Sclerosis; Progressive Multiple Sclerosis Interventions: MSCs; Saline

Keywords

Sources